Cleared Traditional

K110971 - TRACER IMPLANTATION KIT, INDEX IMPLANTATION KIT

K110971 is an FDA 510(k) clearance for TRACER IMPLANTATION KIT, manufactured by Navotek Medical, Ltd.. The device is a Class 2 General & Plastic Surgery device with product code IYE cleared through the Traditional 510(k) pathway after a 279-day FDA review.

K110971 · Navotek Medical, Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 2012
Decision
279d
Days
Class 2
Risk

K110971 is an FDA 510(k) clearance for the TRACER IMPLANTATION KIT, INDEX IMPLANTATION KIT. Classified as Accelerator, Linear, Medical (product code IYE), Class II - Special Controls.

Submitted by Navotek Medical, Ltd. (Philedelphia, US). The FDA issued a Cleared decision on January 10, 2012 after a review of 279 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 892.5050 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K110971

510(k) Number K110971 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 06, 2011
Decision Date January 10, 2012
Days to Decision 279 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
164d slower than avg
Panel avg: 115d · This submission: 279d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IYE Device Classification - Class 2, Special Controls

Product Code IYE Accelerator, Linear, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - IYE Accelerator, Linear, Medical

All 704
Devices cleared under the same product code (IYE) and FDA review panel - the closest regulatory comparables to K110971.
CATALYST
K113276 · C-Rad Positioning AB · Feb 2012
SURFACE BEACON TRANSPONDERS
K112841 · Calypso Medical Technologies, Inc. · Feb 2012
CLARITY OBP SYSTEM
K111332 · Elekta , Ltd. · Jan 2012
VOLUSON E6/E8/E8EXPERT/E10
K113758 · Ge Healthcare · Jan 2012
SMART SEGMENTATION-KNOWLEDGE BASED CONTOURING
K112778 · Varian Medical Systems · Dec 2011
INTEGRITY(TM)
K112613 · Elekta Limited · Dec 2011
K110971 · TRACER IMPLANTATION KIT, INDEX IMPLANTATION KIT
Download PDF FDA Summary Navotek Medical, Ltd.